Research ArticleMetabolism

Controlled-release mitochondrial protonophore (CRMP) reverses dyslipidemia and hepatic steatosis in dysmetabolic nonhuman primates

See allHide authors and affiliations

Science Translational Medicine  02 Oct 2019:
Vol. 11, Issue 512, eaay0284
DOI: 10.1126/scitranslmed.aay0284

Article Information

vol. 11 no. 512

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication May 15, 2019
  • Accepted for publication September 13, 2019
  • .

Author Information

  1. Leigh Goedeke1,
  2. Liang Peng1,
  3. Valle Montalvo-Romeral1,
  4. Gina M. Butrico1,
  5. Sylvie Dufour1,
  6. Xian-Man Zhang1,
  7. Rachel J. Perry1,2,
  8. Gary W. Cline1,
  9. Paul Kievit3,
  10. Keefe Chng4,
  11. Kitt Falk Petersen1 and
  12. Gerald I. Shulman1,2,*
  1. 1Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06510, USA.
  2. 2Department of Cellular and Molecular Physiology, Yale School of Medicine, New Haven, CT 06510, USA.
  3. 3Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
  4. 4Crown Bioscience Louisiana Inc., New Iberia, LA 70560, USA.
  1. *Corresponding author. Email: gerald.shulman{at}yale.edu

Altmetric

Article usage

Article usage: September 2019 to November 2019

AbstractFullPdf
Sep 2019143
Oct 20195134923444
Nov 20191556449